The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture.
Bach MA, Rockwood K, Zetterberg C, Thamsborg G, Hébert R, Devogelaer JP, Christiansen JS, Rizzoli R, Ochsner JL, Beisaw N, Gluck O, Yu L, Schwab T, Farrington J, Taylor AM, Ng J, Fuh V; MK 0677 Hip Fracture Study Group.
Bach MA, et al.
J Am Geriatr Soc. 2004 Apr;52(4):516-23. doi: 10.1111/j.1532-5415.2004.52156.x.
J Am Geriatr Soc. 2004.
PMID: 15066065
Clinical Trial.